Unlocking AI's Potential in Medical Affairs

AI has significant potential to unlock new opportunities in medical affairs within the pharma industry. 

It can support decision-making, enhance patient outcomes, and drive innovation. AI algorithms can analyse real-world data, helping to identify patterns and trends that can inform clinical trial designs, identify patient populations, and support product development and commercialisation. AI-powered chatbots and virtual assistants can improve patient engagement and provide personalised support throughout the healthcare journey.  

Join your peers to discuss how AI is supporting medical affairs teams and more specifically dig into the following questions:  

• How are medical affairs teams currently leveraging AI and how can this technology power decision-making and enhance patient outcomes? 
• How can AI effectively analyse real-world data to identify patterns and trends that inform clinical trial design, patient population identification, and product development in the pharma industry?  
• In what ways can collaboration between different teams in the pharma industry be fostered to effectively harness the full potential of AI in medical affairs and digital health?

We would like to remind you that our meetings are small and intimate sessions with a limited number of seats available, therefore we rely on your attendance and participation to ensure a high quality and valuable meeting for all. If you are confirmed for this meeting we ask if you can please ensure your attendance on the day.